Humana ETF Leadership

HUM Etf  USD 269.78  5.37  2.03%   
Humana employs about 65.7 K people. The company is managed by 64 executives with a total tenure of roughly 299 years, averaging almost 4.0 years of service per executive, having 1026.25 employees per reported executive. Analysis of Humana's management performance can provide insight into the ETF performance.
David Jones  Director
Independent Director
Kurt Hilzinger  Chairman
Independent Chairman of the Board

Insider Sentiment 50

 Impartial

 
Selling
 
Buying

Latest Trades

2025-02-26Gilbert Ray Cisneros, Jr.Acquired @ 255.06
2024-12-31Timothy S HuvalDisposed 3703 @ 256.26View
Monitoring Humana's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.

Acquired vs Disposed

Filed vs Not Filed

Insider sentiment refers to the collective sentiment or feeling of Humana's insiders - typically its officers, directors, and beneficial owners holding more than a certain percentage of the company's stock - about the future prospects of Humana Inc. This sentiment is often gauged based on the trading activities of these insiders. If insiders are purchasing more shares of their own company, it may be interpreted as a bullish sentiment, indicating that they believe Humana's stock will rise in value. Conversely, if insiders are selling shares, it might be seen as bearish, suggesting they expect the stock price to drop.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Humana Inc. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in employment.

Humana's latest congressional trading

Congressional trading in companies like Humana Inc, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Humana by those in governmental positions are based on the same information available to the general public.
2025-03-07Representative Gil CisnerosAcquired Under $15KVerify
2025-02-14Representative Michael McCaulAcquired $15K to $50KVerify
2024-12-18Representative Michael McCaulAcquired $50K to $100KVerify
2024-12-06Representative Ro KhannaAcquired Under $15KVerify
2024-11-11Representative Ro KhannaAcquired Under $15KVerify
2024-09-06Representative John JamesAcquired Under $15KVerify

Humana Management Team Effectiveness

The company has Return on Asset of 0.0407 % which means that on every $100 spent on assets, it made $0.0407 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0741 %, implying that it generated $0.0741 on every 100 dollars invested. Humana's management efficiency ratios could be used to measure how well Humana manages its routine affairs as well as how well it operates its assets and liabilities.

Humana Workforce Comparison

Humana Inc is rated # 5 ETF in number of employees as compared to similar ETFs. The total workforce of Health Care category is currently estimated at about 940,354. Humana holds roughly 65,680 in number of employees claiming about 7% of all ETFs under Health Care category.
The company has Net Profit Margin of 0.01 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of (0.01) %, which entails that for every $100 of revenue, it lost $0.01.

Humana Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Humana insiders, such as employees or executives, is commonly permitted as long as it does not rely on Humana's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Humana insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Celeste Mellet over two months ago
Insider Trading
 
O'hara Michelle A. over two months ago
Insider Trading
 
Smith Brad D over two months ago
Acquisition by Smith Brad D of tradable shares of Humana subject to Rule 16b-3
 
Raquel Bono over three months ago
Acquisition by Raquel Bono of tradable shares of Humana subject to Rule 16b-3
 
Renaudin George Ii over six months ago
Acquisition by Renaudin George Ii of 1241 shares of Humana subject to Rule 16b-3

Humana Notable Stakeholders

A Humana stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Humana often face trade-offs trying to please all of them. Humana's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Humana's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Kurt HilzingerIndependent Chairman of the BoardProfile
Bruce BroussardCEO and President Director and Chairman of Executive CommitteeProfile
Luis OliveraPuerto PresidentProfile
Cynthia ZipperleSenior Vice President, Chief Accounting Officer, ControllerProfile
Alan WheatleySegment President - RetailProfile
James MBAPresident COOProfile
Christopher HunterSegment President, Group and Military BusinessProfile
Susan DiamondChief Financial Officer, Segment President, Home BusinessProfile
David DintenfassPresident GrowthProfile
John IIISenior PresidentProfile
William FlemingSegment President, Pharmacy Solutions and Chief Corporate Affairs OfficerProfile
Bethanie SteinPresident PharmacyProfile
George IIPresident InsuranceProfile
MD MBAPresident CenterWellProfile
Brian KaneChief Financial OfficerProfile
Sam DeshpandeChief Technology Officer, Chief Risk OfficerProfile
Eric TagliereSenior CTOProfile
David JonesIndependent DirectorProfile
David FeinbergIndependent DirectorProfile
Marissa PetersonIndependent DirectorProfile
James OBrienIndependent DirectorProfile
Frank DAmelioIndependent DirectorProfile
Frank BisignanoIndependent DirectorProfile
William McDonaldIndependent DirectorProfile
Karen KatzIndependent DirectorProfile
Joseph RuschellAssistant VPProfile
Joseph VenturaChief Legal Officer and Corporate SecretaryProfile
Vishal MDChief OfficerProfile
Susan SchickSegment President Group and Military BusinessProfile
Raquel BonoIndependent DirectorProfile
Jorge MesquitaIndependent DirectorProfile
W DunbarIndependent DirectorProfile
Heather CarrollChief Digital Health and Analytics OfficerProfile
Kathie ManciniRegional operationsProfile
Kate GoodrichSenior OfficerProfile
Timothy WheatleySegment RetailProfile
Andrew AgwunobiPresident - Home Solutions BusinessProfile
Matt BergerRegional MarketsProfile
Heather CoxChief Digital Health and Analytics OfficerProfile
Michelle OHaraChief OfficerProfile
Jessica ClarkSenior ImprovementProfile
Jennifer BazanteChief Marketing OfficerProfile
Celeste MelletChief OfficerProfile
Amy FrySr CommunicationsProfile
Marcy KlevornIndependent DirectorProfile
Nwando OlayiwolaSenior Vice President Chief Health Equity OfficerProfile
Vishal AgrawalChief Strategy and Corporate Development OfficerProfile
Wayne FrederickIndependent DirectorProfile
PharmD PharmDChief SolutionsProfile
Japan MehtaChief OfficerProfile
Erin ChamplinSenior ExperienceProfile
Timothy HuvalChief Human Resource Officer, Chief Administrative OfficerProfile
Sue SchickPresident - Military and Specialty BusinessesProfile
Gilbert StewartSenior ProductsProfile
T WheatleySegment President - RetailProfile
Tracy NolanSenior MarketPointProfile
Samir DeshpandeChief Information OfficerProfile
William ShrankChief Medical and Corporate Affairs OfficerProfile
John GarrattIndependent DirectorProfile
Carolyn TandySenior Vice President and Chief Inclusion and Diversity OfficerProfile
Jay KhoslaSenior OfficerProfile
JohnPaul FelterChief VPProfile
Lisa StonerVice RelationsProfile
Michael KoeberleinSenior Vice President Chief Accounting Officer, ControllerProfile

About Humana Management Performance

The success or failure of an entity such as Humana Inc often depends on how effective the management is. Humana management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Humana management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Humana management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky. Humana operates under Healthcare Plans classification in the United States and is traded on New York Stock Exchange. It employs 95500 people.
The data published in Humana's official financial statements typically reflect Humana's business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Humana's quantitative information. For example, before you start analyzing numbers published by Humana accountants, it's essential to understand Humana's liquidity, profitability, and earnings quality within the context of the Health Care Providers & Services space in which it operates.

Humana Workforce Analysis

Traditionally, organizations such as Humana use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Humana within its industry.

Humana Manpower Efficiency

Return on Humana Manpower

Revenue Per Employee1.8M
Revenue Per Executive1.8B
Net Income Per Employee18.5K
Net Income Per Executive19M
Working Capital Per Employee5.6K
Working Capital Per Executive5.7M

Other Information on Investing in Humana Etf

Humana financial ratios help investors to determine whether Humana Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Humana with respect to the benefits of owning Humana security.